GRCE aSAH KOL Summary
| GRCE Stock | 3.58 0.32 8.21% |
About 62% of Grace Therapeutics,'s investor base is looking to short. The analysis of overall sentiment of trading Grace Therapeutics, stock suggests that many investors are alarmed at this time. The current market sentiment, together with Grace Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Grace Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Grace |
By John Vandermosten, CFA NASDAQGRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc held a key opinion leader event on November 20 th , 2024 featuring Abhishek Ray, MD of University Hospitals and Andrew Webb, PharmD, BCCCP of Massachusetts General Hospital. The event was hosted by Graces CEO Prashant Kohli. As Grace enters the final stretch of its STRIVE-ON trial
Read at finance.yahoo.com
 |
Grace Therapeutics, Fundamental Analysis
We analyze Grace Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grace Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grace Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Grace Therapeutics, is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Grace Therapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Grace Therapeutics, stock to make a market-neutral strategy. Peer analysis of Grace Therapeutics, could also be used in its relative valuation, which is a method of valuing Grace Therapeutics, by comparing valuation metrics with similar companies.
Peers
Grace Therapeutics, Related Equities
| CNLFF | Canlan Ice | 0.00 |
| ||
| SUM | Summit Materials | 0.08 |
| ||
| MPX | Marine Products | 0.31 |
| ||
| CEIX | Consol Energy | 1.30 |
| ||
| ANPDY | ANTA Sports | 2.19 |
| ||
| APOG | Apogee Enterprises | 2.33 |
| ||
| EGO | Eldorado Gold | 7.42 |
|
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |